Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could lying Head-Down save lives? small trial tests simple fix for low blood pressure in ICU

NCT ID NCT05209737

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early This study
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This small pilot study tested whether placing critically ill patients with low blood pressure in a head-down tilt (Trendelenburg) position could improve organ function by reducing the need for fluids and blood-pressure-raising drugs. The study included 10 sedated, ventilated patients in the ICU with conditions like septic shock. The approach was compared to standard semi-upright care, but the trial was terminated early, so results are limited.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

10 people

The number who actually took part.

Started

Jan 2022

Finished

Nov 2025

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age \>18 years * Admitted to the intensive care unit (ICU); * Invasive mechanical ventilation; * Pharmacological sedation; * Mean arterial pressure (MAP)\<65 mmHg or need of fluids infusion or any vasopressor in order to keep MAP \> 65 mmHg * Ongoing invasive and/or non-invasive arterial blood pressure monitoring * Central venous line with central venous pressure (CVP) monitoring * Naso-gastric tube in situ * Indwelling bladder catheter * Consent according to local ethical committee rules Exclusion Criteria: * Body mass index \> 45 * Documented or suspected increased intracranial pressure, based on medical history or actual clinical condition (es. intracranial tumor, cerebral hemorrhage, encephalitis,...); * Intra-abdominal hypertension \>25 mmHg * Documented or suspected increased intraocular pressure (any degree of glaucoma) * Full stomach pyloric incontinence; * Gastric stasis, defined as aspiration from the NG (nasogastric) tube of fecal, bloody, or green fluid greater than 100 mL upon insertion of the tube or within the preceding hour; * Ongoing enteral nutrition * No central line inserted or femoral central line only * Not sutured known diaphragm lesions * Known hiatus hernia * Aortic bifurcation and/or lower extremity arterial stenosis ≥70% combined with stage 3 intermittent claudication (pain at rest) * Patients who are not able to be investigated with a leg raising test (eg lower extremities fractures, backbone fractures or backbone pain or deformity, and those patients with large cannulas in the femoral vessels) * Demand of specific postures (eg Trauma, fractures, backbone pain or deformity, patients with large cannulas in the femoral vessels, pronation including first pronation planned within 6 h…) * Any device which, according to the clinician, makes it unfeasible or unsafe to put patients in the Trendelenburg position (eg Drainage in thoracic cavity) * Mechanical Circulatory Support; * (CHD) (Gleen, Fontaine); * Advanced right ventricular dysfunction or advanced cardiac failure, in which volume overload worsens cardiac function (plateau stage in the Frank-Starling curve); * Actual upper gastrointestinal bleeding * Passive leg raising test non-responder

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hypotension are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Demikhov Municipal Clinical Hospital 68

    Moscow, Russia

  • Vishnevsky Center of Surgery

    Moscow, 117997, Russia

More trials for these conditions

Other studies related to the condition(s) this trial covers.